Giiant Pharma

Montréal, Canada

Giiant Pharma is a preclinical-stage biotech company.

$500K raised

Dec 2023

Grant

Biopharma Biotechnology Health Care Life Science

Top Investors

Fonds de solidarité FTQ Amplitude Venture Capital Genesys Capital AQC Capital Amorchem

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Giiant Pharma

How much funding has Giiant Pharma raised?

Giiant Pharma has raised $500K in total funding. The most recent round was Grant. The last funding was announced in December 2023.

Who are Giiant Pharma's investors?

Giiant Pharma's investors include Fonds de solidarité FTQ, Amplitude Venture Capital, Genesys Capital, AQC Capital, Amorchem.

Where is Giiant Pharma headquartered?

Giiant Pharma is headquartered in Montréal, Canada.

What does Giiant Pharma do?

Giiant Pharma is a preclinical-stage biotech company.

What stage is Giiant Pharma at?

Giiant Pharma is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 28, 2023.

MLA

"Giiant Pharma — Funding & Investors." VCBacked, December 28, 2023, https://www.vcbacked.co/company/giiant-pharma. Accessed July 2, 2026.

APA

VCBacked. (2023). Giiant Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/giiant-pharma

Wikipedia (cite web)

{{cite web |title=Giiant Pharma — Funding & Investors |url=https://www.vcbacked.co/company/giiant-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 28, 2023.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.